查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829255

2025年结核病诊断全球市场报告

Tuberculosis Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，结核病诊断市场规模强劲成长，从2024年的22.1亿美元增加至2025年的23.4亿美元，复合年增长率为5.9%。这段时期的成长归因于结核病发病率上升、医疗支出增加、医疗机构数量增加以及核酸检测普及率提高。

预计未来几年结核病诊断市场规模将强劲成长，2029年将达到31.5亿美元，复合年增长率为7.7%。预测期内的成长可归因于政府的大力支持、美国食品药物管理局（FDA）对结核病诊断产品核准的不断增加、研发活动的活性化以及抗药性结核病的出现。预测期内的主要趋势包括：关注结核病诊断的新一代定序 (NGS) 平台、产品创新、结核病感染的T细胞​​检测、基于人工智慧 (AI) 的结核病诊断、便携式设备的使用以及政府与製造商的合作。

结核病诊断技术包括用于诊断结核病和监测治疗结果的高灵敏度和特异性工具和检测方法。这些检测旨在识别临床检体中的抗酸桿菌 (AFB) 并检测结核病。

结核病诊断市场包括各种类型的测试，例如X光、实验室测试、细胞激素测试、细胞因子检测测试、抗药性测试、皮肤测试（TST）/ Mantoux测试、血液/血清学测试、涂片显微镜检查、基于细胞培养的测试和其他方法。 X光用于识别指示结核病症状的胸部异常。这些测试着重于诊断可能出现在肺部任何位置的病变，包括空腔、密度、大小和形状的变化。这些诊断方法包括核酸检测（NAT）、皮肤测试或Mantoux测试（TST）、血液/血清学测试、涂片显微镜检查、基于细胞培养的测试、放射线照相术和其他方法。这些测试针对结核病的各个阶段，包括潜伏性结核病和活动性结核病。结核病诊断的最终使用者包括医院、诊断实验室、临床实验室、参考实验室、学术机构和研究机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制价格上涨，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、加强标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供结核病诊断市场统计数据，例如全球结核病诊断行业规模、各地区份额、结核病诊断市场份额竞争对手、详细的结核病诊断细分市场、市场趋势和商业机会，以及您在结核病诊断行业取得成功所需的数据。本结核病诊断市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年7.7%的预测成长率，较我们先前对该市场的预测略有下降0.5%。下降的主要原因是美国与其他国家之间的关税影响。由于来自法国和印度等主要地区的分枝桿菌培养基和基因萃取物试剂盒组件的供应链中断，美国可能会直接感受到这一影响，这可能导致检测延迟并增加结核病筛检计画的成本。

结核病 (TB) 发病率的不断上升推动了结核病诊断市场的需求。结核病是严重的感染疾病，主要影响肺部，透过咳嗽和打喷嚏时释放到空气中的微小细菌传播。有效的结核病诊断方法在疾病的早期发现和诊断中发挥关键作用。例如，2023 年 3 月，美国国家公共卫生机构疾病管制与预防中心 (CDC) 报告称，2022 年美国结核病病例数为 8,300 例，高于 2021 年的 7,874 例。结核病病例的增加正在推动结核病诊断市场的成长。

美国食品药物管理局(FDA)核准的结核病诊断产品数量不断增加，预计将进一步推动市场成长。例如，2023 年 3 月，英国医疗诊断公司 PerkinElmer Oxford Immunotec 宣布，已获得 FDA核准使用另外两种细胞分离设备，即 Allsheng Instruments 生产的 Auto-Pure 24 和 Auto-Pure 20B 平台。此外，2022 年 10 月，PerkinElmer Oxford Immunotec 获得 FDA核准使用其 T-Cell Select试剂组，有助于获得认可的实验室实现体外诊断 (IVD) T-SPOT.TB 检测工作流程的自动化。 T-Cell Select 是一种週边血单核细胞 (PBMC) 分离试剂，它透过以微珠为基础的细胞分离对 PBMC 进行阳性选择，从而简化了 T-SPOT.TB 测试的细胞製备，T-SPOT.TB 测试是一种受国际监管的 ELISPOT IGRA，旨在检测潜伏性结核感染。预计 FDA 对新型结核病诊断核准的批准将加强并推动结核病诊断市场的成长。

影响结核病诊断市场的一个共同趋势是技术创新的采用，主要市场参与企业积极采用先进技术以保持其市场地位。特别是，利用人工智慧 (AI) 技术的先进照护现场(POC) 方法的采用正在取得进展。一个例子是日本医学影像设备製造商富士胶片与专门从事基于 AI 的医学影像解决方案的美国公司 Qure.ai 之间的合作。 2022 年 8 月，两家公司联合宣布了一种利用电池供电的X光设备进行结核病诊断的先进即时诊断方法。人工智慧演算法的整合增强了测试程序，为照护现场诊断提供了一种超可携式、高精度和高效的解决方案。

结核病诊断市场的一个显着趋势是，随着企业努力保持竞争力并满足不断变化的消费者需求和偏好，他们越来越注重产品创新。产品创新在吸引爱好者、推动销售和提高品牌知名度方面发挥关键作用。结核病诊断领域的企业正积极致力于开发新的产品解决方案，以巩固其市场地位。一个值得注意的例子是印度技术力增强型诊断服务供应商Redcliffe Labs，该公司于 2023 年 2 月推出了 BD MAX MDR TB（结核病）测试。此诊断测试在 BD MAX 分子诊断系统上进行，使临床医生能够快速检测结核病和多重抗药性作为第一线测试。临床医生使用该测试来检测致结核病细菌，同时确定细菌是否表现出与对两种重要的一线药物异烟肼 (INH) 和利福平 (RIF) 的抗药性相关的突变。这种对产品创新的关注对于加强公司在结核病诊断市场的地位至关重要。

2023年8月，总部位于美国的科技公司丹纳赫集团以每股约24美元的价格收购了Abcam plc，总价超过57亿美元。此次收购旨在利用Abcam plc丰富的高品质试剂和抗体产品组合，巩固丹纳赫集团在生命科学领域的地位。这将增强丹纳赫在科学研究开发方面的能力，并满足市场对先进生物研究工具日益增长的需求。总部位于英国的生技公司Abcam plc也提供结核病诊断产品。

结核病诊断市场的主要企业包括 Beckton、Dickinson and Company、F. Hoffmann-La Roche Ltd、Qiagen NV、BioMerieux SA、Danaher Corporation、PerkinElmer、Thermo Fisher Scientific Inc、Creative Diagnostics、Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc、Creative Diagnostics、Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc、Creative Diagnostics.Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc、Creative Diagnostics.Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc、Creative Diagnostics.Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc、Creative Diagnostics.Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc. Clinical Laboratories、广州金域医学检验中心有限公司、Kindstar Global、OriGene Technologies、Siemens AG、LumiraDx Limited、TestLine Clinical Diagnostics sro、Hologic、Bayer AG、Meridian Bioscience、Agilott laboratories Immunagnostices​​an Pc​​yagnostic Holdings Holdings Psa gilnotech、Atechnxia Inc. Limited、Gen-Probe、Sysmex South Africa (Pty) Ltd.、Bio Certica 和 BixBio。

2024 年，亚太地区是结核病诊断市场最大的地区。结核病诊断市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

结核病诊断市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙和加拿大。

结核病诊断市场涵盖提供诊断实验室方法、潜伏感染检测、抗药性检测和诊断实验室检测相关服务的营业单位的收益。市场规模还包括服务提供者销售或包含在其服务产品中的相关商品的价值。仅包括营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球结核病诊断：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球结核病诊断市场：成长率分析
  • 全球结核病诊断市场表现：规模与成长，2019-2024
  • 全球结核病诊断市场预测：规模与成长，2024-2029年，2034年
  • 全球结核病诊断：总目标市场（TAM）

第六章 市场细分

  • 全球结核病诊断市场（按检测类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 放射线检查
  • 核酸检测
  • 细胞激素检测试验
  • 抗药性检测
  • 皮肤测试/结核菌素试验 (TST)
  • 血液/血清检测
  • 涂片显微镜检查
  • 细胞培养测试
  • 其他的
  • 全球结核病诊断市场（依疾病阶段、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 潜伏性结核病
  • 活动性结核病
  • 全球结核病诊断市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊断实验室
  • 门诊检查室
  • 参考实验室
  • 学术研究设施
  • 全球结核病诊断市场：放射学细分市场、类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 胸部X光检查
  • 电脑断层扫描
  • 全球结核病诊断市场：核酸检测细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应（PCR）
  • 核酸增幅检查（NAAT）
  • 全球结核病诊断市场：细胞激素检测测试细分（按类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 干扰素-γ释放试验（IGRA）
  • 全球结核病诊断市场：抗药性检测细分、类型、绩效及预测（2019-2024、2024-2029、2034）
  • GeneXpert MTB/RIF
  • 线探针分析
  • 全球结核病诊断市场：皮肤测试/结核菌素试验（TST）细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 结核菌素皮肤试验（TST）
  • 全球结核病诊断市场：血液/血清学检测细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 抗体血清学检测
  • 全球结核病诊断市场：涂片显微镜细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 抗酸桿菌（AFB）涂片检查
  • 全球结核病诊断市场：基于细胞培养的测试细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 固态培养基培养
  • 液体培养基培养
  • 全球结核病诊断市场：其他细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 分子检测
  • 先进的成像技术

第七章 区域和国家分析

  • 全球结核病诊断市场：2019-2024 年、2024-2029 年和 2034 年区域表现和预测
  • 全球结核病诊断市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 结核病诊断市场：竞争格局
  • 结核病诊断市场：公司简介
    • Beckton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd
    • Qiagen NV
    • BioMerieux SA
    • Danaher Corporation

第31章：其他领先和创新企业

  • PerkinElmer
  • Thermo Fisher Scientific Inc.
  • Creative Diagnostics
  • Lionex GmbH
  • Biocartis
  • Bio-Techne India Private Limited
  • Bio-Rad Laboratories India Pvt.Ltd
  • Zhejiang Di'an Diagnostics Technology Co., Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global
  • OriGene Technologies
  • Siemens AG
  • LumiraDx Limited
  • TestLine Clinical Diagnostics sro

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年结核病诊断市场：提供新机会的国家
  • 2029 年结核病诊断市场：细分市场将带来新机会
  • 2029年结核病诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r26008u

Tuberculosis diagnostics encompass tools or tests characterized by high sensitivity and specificity in diagnosing TB and monitoring treatment effectiveness. They aim to identify acid-fast bacilli (AFB) in clinical samples and detect tuberculosis.

The tuberculosis diagnostics market comprises various types of tests such as radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test (TST)/Mantoux test, blood/serology tests, smear microscopy tests, cell culture-based tests, and other methods. Radiographic tests are utilized to identify chest abnormalities indicative of tuberculosis symptoms. These tests focus on diagnosing lesions that can manifest anywhere in the lungs, differing in cavitation, density, size, and shape. These diagnostic methods encompass nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and other approaches. They serve various disease stages such as latent tuberculosis and active tuberculosis. End-users of tuberculosis diagnostics include hospitals, diagnostic laboratories, physician's office laboratories, reference laboratories, academic institutions, and research facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.21 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the rise in the incidence of tuberculosis, increased healthcare expenditure, growth in the number of healthcare facilities, and the rise in the adoption of nucleic acid testing.

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.15 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to strong government support, the increasing FDA approvals for tuberculosis diagnostics, the increasing research and development (R&D) activities, and the emergence of drug-resistant TB. Major trends in the forecast period include a focus on next-generation sequencing (NGS) platforms for TB diagnostics, product innovations, t-cell tests for TB infection, artificial intelligence (AI)-based tuberculosis diagnostics, use of portable devices, and collaborations between governments and manufacturers.

The forecast of 7.7% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for mycobacterium culture media and GeneXpert cartridge components, sourced from key regions such as France and India, could lead to testing delays and higher costs for tuberculosis (TB) screening programs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of tuberculosis is boosting demand for the tuberculosis diagnostics market. Tuberculosis is a severe infectious disease primarily affecting the lungs and is transmitted through coughing and sneezing, which release tiny germs into the air. Effective tuberculosis diagnostics play a crucial role in early detection and diagnosis of the disease. For example, in March 2023, the Centers for Disease Control and Prevention (CDC), a US-based national public health organization, reported 8,300 cases of tuberculosis (TB) in the United States in 2022, up from 7,874 cases in 2021. This rise in tuberculosis cases is driving growth in the tuberculosis diagnostics market.

The growing number of approvals from the US Food and Drug Administration (FDA) for tuberculosis diagnostics will further bolster market growth. An illustrative instance is the announcement made in March 2023 by PerkinElmer Oxford Immunotec, a UK-based medical diagnostics company, regarding the FDA approval for the use of two additional cell isolation instruments, Auto-Pure 24 and Auto-Pure 20B platforms, manufactured by Allsheng Instruments. Additionally, in October 2022, PerkinElmer Oxford Immunotec received FDA approval for the use of the T-Cell Select reagent kit, facilitating the automation of the T-SPOT.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories. T-Cell Select, a peripheral blood mononuclear cell (PBMC) isolation reagent, employs positive selection of PBMCs with magnetic bead-based cell separation to streamline the preparation of cells for the T-SPOT.TB test-an internationally regulated ELISPOT IGRA designed for detecting latent tuberculosis infection. This influx of FDA approvals for novel tuberculosis diagnostics is anticipated to reinforce and drive the growth of the tuberculosis diagnostics market.

The prevailing trend shaping the tuberculosis diagnostics market is the adoption of technological innovations, with major market players actively integrating advanced technologies to maintain their market standing. Notably, companies are introducing sophisticated point-of-care (POC) diagnostic methods leveraging artificial intelligence (AI) technology. A case in point is the collaboration between Fujifilm, a Japan-based medical imaging device manufacturer, and Qure.ai, a US-based company specializing in AI-enabled medical imaging solutions. In August 2022, they jointly launched an advanced POC diagnostic method utilizing a battery-powered X-ray machine for tuberculosis diagnosis. The integration of artificial intelligence algorithms enhances testing programs, offering ultra-portability, high accuracy, and efficient solutions for point-of-care diagnostics.

A prominent trend in the tuberculosis diagnostics market is the emphasis on product innovations as companies strive to remain competitive and meet evolving consumer needs and preferences. Product innovation plays a pivotal role in generating enthusiasm, driving sales, and increasing brand awareness. Companies in the tuberculosis diagnostics sector are actively focusing on developing new product solutions to fortify their market positions. A noteworthy example is Redcliffe Labs, an India-based technology-empowered diagnostics service provider, which, in February 2023, introduced the BD MAX MDR TB (Tuberculosis) test. This diagnostic test, performed on the BD MAX molecular diagnostic system, enables clinicians to rapidly test for tuberculosis and multidrug resistance as a first-line test. Clinicians use the test to simultaneously detect bacteria causing TB and ascertain whether the bacteria exhibit mutations associated with resistance to two vital first-line drugs, Isoniazid (INH) and Rifampicin (RIF). This focus on product innovation is integral to strengthening companies' positions within the tuberculosis diagnostics market.

In August 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc for approximately $24.00 per share, totaling over $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by utilizing Abcam plc's extensive portfolio of high-quality reagents and antibodies. This will enhance Danaher's capabilities in scientific research and development, allowing it to better meet the growing demand for advanced biological research tools. Abcam plc, a UK-based biotechnology company, also provides tuberculosis diagnostics.

Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tuberculosis Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tuberculosis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tuberculosis diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tuberculosis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
  • 2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
  • 3) By End-User: Hospitals And Diagnostic Laboratories, Physician's Office Laboratories, Reference Laboratories, Academics And Research Facilities
  • Subsegments:
  • 1) By Radiographic Tests: Chest X-rays; CT Scans
  • 2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Tests (NAATs)
  • 3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
  • 4) By Drug Resistance Tests: GeneXpert MTB/RIF; Line Probe Assays
  • 5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
  • 6) By Blood Or Serology Test: Serological Tests for Antibodies
  • 7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
  • 8) By Cell Culture-Based Tests: Solid Media Cultures; Liquid Media Cultures
  • 9) By Other Test Types: Molecular Tests; Advanced Imaging Techniques
  • Companies Mentioned: Beckton, Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation; PerkinElmer; Thermo Fisher Scientific Inc.; Creative Diagnostics; Lionex GmbH; Biocartis; Bio-Techne India Private Limited; Bio-Rad laboratories India Pvt.Ltd; Zhejiang Di'an Diagnostics Technology Co., Ltd; ADICON Clinical Laboratories; Guangzhou Kingmed Diagnostics Center Co. Ltd.; Kindstar Global; OriGene Technologies; Siemens AG; LumiraDx Limited; TestLine Clinical Diagnostics s.r.o.; Hologic; Bayer AG; Meridian Bioscience; Abbott laboratories Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc; Agilent technologies Inc; Akonni Biosystems Inc; Epistem Limited; Gen-Probe; Sysmex South Africa (Pty) Ltd.; Bio Certica; BixBio
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tuberculosis Diagnostics Market Characteristics

3. Tuberculosis Diagnostics Market Trends And Strategies

4. Tuberculosis Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tuberculosis Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tuberculosis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tuberculosis Diagnostics Market Growth Rate Analysis
  • 5.4. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tuberculosis Diagnostics Total Addressable Market (TAM)

6. Tuberculosis Diagnostics Market Segmentation

  • 6.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiographic Tests
  • Nucleic Acid Testing
  • Cytokine Detection Tests
  • Drug Resistance Tests
  • Skin Test / Mantoux Test (TST)
  • Blood/Serology Test
  • Smear Microscopy Tests
  • Cell Culture-Based Tests
  • Other Test Types
  • 6.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Latent Tuberculosis
  • Active Tuberculosis
  • 6.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Laboratories
  • Physician's Office Laboratories
  • Reference Laboratories
  • Academics And Research Facilities
  • 6.4. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chest X-rays
  • CT Scans
  • 6.5. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Nucleic Acid Amplification Tests (NAATs)
  • 6.6. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Interferon Gamma Release Assays (IGRAs)
  • 6.7. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • GeneXpert MTB/RIF
  • Line Probe Assays
  • 6.8. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tuberculin Skin Test (TST)
  • 6.9. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serological Tests for Antibodies
  • 6.10. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Acid-Fast Bacilli (AFB) Smear Test
  • 6.11. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Media Cultures
  • Liquid Media Cultures
  • 6.12. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Tests
  • Advanced Imaging Techniques

7. Tuberculosis Diagnostics Market Regional And Country Analysis

  • 7.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tuberculosis Diagnostics Market

  • 8.1. Asia-Pacific Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tuberculosis Diagnostics Market

  • 9.1. China Tuberculosis Diagnostics Market Overview
  • 9.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tuberculosis Diagnostics Market

  • 10.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tuberculosis Diagnostics Market

  • 11.1. Japan Tuberculosis Diagnostics Market Overview
  • 11.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tuberculosis Diagnostics Market

  • 12.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tuberculosis Diagnostics Market

  • 13.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tuberculosis Diagnostics Market

  • 14.1. South Korea Tuberculosis Diagnostics Market Overview
  • 14.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tuberculosis Diagnostics Market

  • 15.1. Western Europe Tuberculosis Diagnostics Market Overview
  • 15.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tuberculosis Diagnostics Market

  • 16.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tuberculosis Diagnostics Market

  • 17.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tuberculosis Diagnostics Market

  • 18.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tuberculosis Diagnostics Market

  • 19.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tuberculosis Diagnostics Market

  • 20.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tuberculosis Diagnostics Market

  • 21.1. Eastern Europe Tuberculosis Diagnostics Market Overview
  • 21.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tuberculosis Diagnostics Market

  • 22.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tuberculosis Diagnostics Market

  • 23.1. North America Tuberculosis Diagnostics Market Overview
  • 23.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tuberculosis Diagnostics Market

  • 24.1. USA Tuberculosis Diagnostics Market Overview
  • 24.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tuberculosis Diagnostics Market

  • 25.1. Canada Tuberculosis Diagnostics Market Overview
  • 25.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tuberculosis Diagnostics Market

  • 26.1. South America Tuberculosis Diagnostics Market Overview
  • 26.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tuberculosis Diagnostics Market

  • 27.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tuberculosis Diagnostics Market

  • 28.1. Middle East Tuberculosis Diagnostics Market Overview
  • 28.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tuberculosis Diagnostics Market

  • 29.1. Africa Tuberculosis Diagnostics Market Overview
  • 29.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Tuberculosis Diagnostics Market Competitive Landscape
  • 30.2. Tuberculosis Diagnostics Market Company Profiles
    • 30.2.1. Beckton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Qiagen N.V Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tuberculosis Diagnostics Market Other Major And Innovative Companies

  • 31.1. PerkinElmer
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Creative Diagnostics
  • 31.4. Lionex GmbH
  • 31.5. Biocartis
  • 31.6. Bio-Techne India Private Limited
  • 31.7. Bio-Rad Laboratories India Pvt.Ltd
  • 31.8. Zhejiang Di'an Diagnostics Technology Co., Ltd
  • 31.9. ADICON Clinical Laboratories
  • 31.10. Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • 31.11. Kindstar Global
  • 31.12. OriGene Technologies
  • 31.13. Siemens AG
  • 31.14. LumiraDx Limited
  • 31.15. TestLine Clinical Diagnostics s.r.o.

32. Global Tuberculosis Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

34. Recent Developments In The Tuberculosis Diagnostics Market

35. Tuberculosis Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Tuberculosis Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tuberculosis Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tuberculosis Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer